指南与共识肝胆胰外科围术期管理与 ERAS

E-AHPBA-ESSO-ESSR因斯布鲁克共识指南:肝切除术术前肝功能评估

E-AHPBA-ESSO-ESSR Innsbruck consensus guidelines for preoperative liver function assessment before hepatectomy.
指南 / 共识 · Br J Surg · 2023-01-01

该欧洲共识指南采用改良Delphi法,由肝胆外科、放射科、核医学和肝病专家组成专家组,基于271篇文献制定21条声明(一致率至少85%),为肝切除术前肝功能评估提供指导。指南建议复杂肝切除及疑有基础肝病或化疗相关肝损伤者应评估术前肝功能,未来肝剩余体积测量是基础,可结合吲哚菁绿清除率或LiMAx®。

要点

  • 复杂肝切除或疑有基础肝病、化疗相关或药物性肝损伤者应考虑术前肝功能评估。
  • 临床评估和基于血液的评分(如白蛋白/胆红素、血小板计数)有助于识别肝切除术后肝衰竭风险。
  • 未来肝剩余体积测量是评估基础,可根据本地经验和条件结合吲哚菁绿清除率或LiMAx®。

核心结论

  • 指南反映了评估术前肝功能和肝切除术后肝衰竭风险的既定方法,并揭示了未来研究感兴趣的证据空白。
  • 肝手术是肝脏肿瘤的有效治疗,肝功能差或接受大手术的患者肝衰竭是主要问题,治疗选择有限且死亡率高,术前评估肝功能以估计风险很重要。

研究设计与样本

  • 采用改良Delphi法达成共识,专家组包括肝胆外科医生、放射科医生、核医学专家和肝病专家,指南过程由方法学家监督并由患者代表审查。
  • 在PubMed/MEDLINE、Cochrane图书馆和WHO国际临床试验注册平台进行系统文献检索,证据评估和声明制定遵循苏格兰校际指南网络方法。

主要发现

  • 基于271篇涵盖4个关键领域的文献,产生21条声明(一致率至少85%),中位证据水平为2-至2+。
  • 仅识别出少数系统综述(2++)和一项随机对照试验(1+)。

关键数值与推荐

  • 复杂肝切除前、以及疑有或已知基础肝病、化疗相关或药物性肝损伤的患者,应考虑术前肝功能评估。
  • 反映肝功能或门静脉高压的临床评估和基于血液的评分(例如白蛋白/胆红素、血小板计数)有助于识别肝切除术后肝衰竭风险。
  • 未来肝剩余体积测量是评估的基础,可根据本地经验和条件结合吲哚菁绿清除率或LiMAx®。
  • 功能MRI和肝脏闪烁显像是替代方法,可在一次检查中结合未来肝剩余体积和功能。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 仅识别出少数系统综述(2++)和一项随机对照试验(1+)。
  • 指南揭示了未来研究感兴趣的证据空白。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Posthepatectomy liver failure (PHLF) contributes significantly to morbidity and mortality after liver surgery. Standardized assessment of preoperative liver function is crucial to identify patients at risk. These European consensus guidelines provide guidance for preoperative patient assessment. METHODS: A modified Delphi approach was used to achieve consensus. The expert panel consisted of hepatobiliary surgeons, radiologists, nuclear medicine specialists, and hepatologists. The guideline process was supervised by a methodologist and reviewed by a patient representative. A systematic literature search was performed in PubMed/MEDLINE, the Cochrane library, and the WHO International Clinical Trials Registry. Evidence assessment and statement development followed Scottish Intercollegiate Guidelines Network methodology. RESULTS: Based on 271 publications covering 4 key areas, 21 statements (at least 85 per cent agreement) were produced (median level of evidence 2- to 2+). Only a few systematic reviews (2++) and one RCT (1+) were identified. Preoperative liver function assessment should be considered before complex resections, and in patients with suspected or known underlying liver disease, or chemotherapy-associated or drug-induced liver injury. Clinical assessment and blood-based scores reflecting liver function or portal hypertension (for example albumin/bilirubin, platelet count) aid in identifying risk of PHLF. Volumetry of the future liver remnant represents the foundation for assessment, and can be combined with indocyanine green clearance or LiMAx® according to local expertise and availability. Functional MRI and liver scintigraphy are alternatives, combining FLR volume and function in one examination. CONCLUSION: These guidelines reflect established methods to assess preoperative liver function and PHLF risk, and have uncovered evidence gaps of interest for future research. Liver surgery is an effective treatment for liver tumours. Liver failure is a major problem in patients with a poor liver quality or having large operations. The treatment options for liver failure are limited, with high death rates. To estimate patient risk, assessing liver function before surgery is important. Many methods exist for this purpose, including functional, blood, and imaging tests. This guideline summarizes the available literature and expert opinions, and aids clinicians in planning safe liver surgery.

来源:Br J Surg,查看原文。版权归原作者所有。

引用

  1. Primavesi F, Maglione M, Cipriani F, et al. E-AHPBA-ESSO-ESSR Innsbruck consensus guidelines for preoperative liver function assessment before hepatectomy. Br J Surg. 2023. PMID: 37572099. doi:10.1093/bjs/znad233

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。